A Clinical Study to Assess the Gingivitis Effects of Various Dentifrices

NCT06140771 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

115

Enrollment

INDUSTRY

Sponsor class

Conditions

Gingivitis

Interventions

DRUG: 0.76% Sodium Monofluorophosphate Dentifrice
DRUG: 1.15% Sodium Monofluorophosphate Dentifrice
DRUG: 0.454% Stannous Fluoride Dentifrice
DRUG: 0.454% Stannous Fluoride Dentifrice

Sponsor

Procter and Gamble